.png)
At diagnosis, many breast cancer patients are overweight or obese, worsening outcomes. Obesity-related hyperleptinemia fuels cancer metastasis, and leptin may play a critical role in angiogenesis—key to tumor growth and spread. Understanding leptin's role could shape future therapies for obese patients.
Riboflavin (vitamin B2) is crucial for energy metabolism and biosynthetic processes as a precursor to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Deficiency is common and particularly affects women's health due to increased needs during hormonal fluctuations, pregnancy, and breastfeeding. Innovative strategies, like riboflavin-producing lactic acid bacteria, can enhance riboflavin intake while providing probiotic benefits. Lactobacillus species are especially important for vaginal health and gut microbiota. This review explores the molecular mechanisms and health benefits of riboflavin for women, emphasizing the synergistic potential of riboflavin-producing probiotics to meet dietary needs and support overall well-being.
CDK4/6 inhibitors combined with endocrine therapy significantly improve efficacy in HR+/HER2- advanced breast cancer first-line treatment. Adding immune checkpoint inhibitors enhances outcomes in second-line settings, though more trials are needed.
Source : https://pubmed.ncbi.nlm.nih.gov/38326452/
Individual trials of abemaciclib, palbociclib, and ribociclib show a similar impact on progression-free survival yet differing statistical significance for overall survival (OS). A robust comparative evaluation of OS, safety, and...
A network meta-analysis of CDK4/6 inhibitors in ER-positive/HER2-negative breast cancer shows no OS difference but highlights safety variations, with abemaciclib having higher GI toxicity and treatment discontinuation rates.
Source : https://pubmed.ncbi.nlm.nih.gov/38058163/
Males account for 1% of all cases of breast cancer. With the aging of the world's population, the disease has exhibited a rise in incidence in recent decades. Male breasts...
This review discusses male breast cancer's rising incidence, clinical features, and management challenges, emphasizing the importance of awareness and research due to its rarity and similarities to female cases.